Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors
Open Access
Abstract
Inhibitors of human lactate dehydrogenase (hLDH5)—the enzyme responsible for the conversion of pyruvate to lactate coupled with oxidation of NADH to NAD+—are promising therapeutic agents against cancer because this enzyme is generally found to be overexpressed in most invasive cancer cells and is linked to their vitality especially under hypoxic conditions. Consequently, significant efforts have been made for the identification of small-molecule hLDH5 inhibitors displaying high inhibitory potencies. X-ray structure of hLDH5 complexes as well as molecular modeling studies contribute to identify and explain the main binding modes of hLDH5 inhibitors reported in literature. The purpose of this review is to analyze the main three-dimensional interactions between some of the most potent inhibitors and hLDH5, in order to provide useful suggestions for the design of new derivatives.Keywords
This publication has 38 references indexed in Scilit:
- Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against CancerJournal of Agricultural and Food Chemistry, 2017
- Lactate dehydrogenase A promotes the invasion and proliferation of pituitary adenomaScientific Reports, 2017
- HIF1/2α mediates hypoxia-induced LDHA expression in human pancreatic cancer cellsOncotarget, 2017
- Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in MiceACS Medicinal Chemistry Letters, 2016
- Fundamentals of cancer metabolismScience Advances, 2016
- Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenaseBioorganic & Medicinal Chemistry Letters, 2015
- Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenaseBioorganic & Medicinal Chemistry Letters, 2014
- Anticancer Agents That Counteract Tumor GlycolysisChemMedChem, 2012
- Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenanceCancer Cell, 2006
- Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosisBritish Journal of Cancer, 2003